Neumedicines' proposal, 'Recombinant Interleukin-12, a Broad-Spectrum Biologic for the Treatment of Battle and Traumatic Wound Infections,' was submitted in response to the Fiscal Year 2014 and Development Program Military Infectious Diseases Clinical Trial Award , which is solicited for the Assistant Secretary of Defense for Health Affairs, ... (more)
http://ift.tt/1m0N8Y5
http://ift.tt/1m0N8Y5
No comments:
Post a Comment